Skip to main content

Table 5 The associations between PDI and birth outcomes among pregnant women with available dietary data (n = 712)

From: Adverse associations between maternal deoxynivalenol exposure and birth outcomes: a prospective cohort study in China

 

Birth weight (g)

Birth length (cm)

Small for gestational age

β (95%CI)

β (95%CI)

Case (%)

OR (95%CI)

PDI

Ln-PDI

-30.79 (-52.94, -8.64)

-0.06 (-0.14, 0.03)

66 (9.27)

1.13 (0.91, 1.41)

Tertiles

 T1

ref

ref

19 (7.88)

ref

 T2

-10.62 (-74.94, 53.70)

0.05 (-0.19, 0.30)

18 (7.11)

0.94 (0.47, 1.86)

 T3

-112.24 (-179.54, -44.94)

-0.31 (-0.57, -0.06)

29 (13.30)

1.78 (0.95, 3.34)

 P for trend

 < 0.001

0.005

 

0.036

Dichotomous value

 < PMTDI

ref

ref

36 (7.56)

ref

 ≥ PMTDI

-103.69 (-160.99, -46.39)

-0.36 (-0.57, -0.14)

30 (12.71)

1.71 (1.01, 2.91)

  1. Abbreviations: PDI provisional daily intake, DON deoxynivalenol, PMTDI provisional maximum tolerable daily intake, OR odds ratio, CI confidence interval
  2. Adjusted Model: adjusted for age, pre-pregnancy BMI, average personal income, education attainment, parity, abnormal pregnancy-labor history, morning sickness, alcohol intake, smoking, season of sample collection, infant sex, gestational age at delivery, and cereal intake